ASP-II: Ancrod Stroke Program: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke

Summary

The primary purpose of this study is to determine whether a brief intravenous infusion of ancrod started within 6 hours of stroke onset improves functional outcome at 3 months.

Timeline

Start

2006-03

Primary completion

2008-12

Completion

2008-12

Outcome

Outcome not reported

Stopped: “Futility”

Drugs

Indications